Personal Capital Advisors Corp - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 269 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.

Quarter-by-quarter ownership
Personal Capital Advisors Corp ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$478,188
+44.0%
8,4040.0%0.00%0.0%
Q3 2022$332,000
-10.3%
8,4040.0%0.00%0.0%
Q2 2022$370,000
+10.4%
8,4040.0%0.00%0.0%
Q1 2022$335,000
-15.8%
8,404
-15.2%
0.00%0.0%
Q4 2021$398,000
-1.2%
9,9070.0%0.00%0.0%
Q3 2021$403,000
-10.4%
9,9070.0%0.00%0.0%
Q2 2021$450,000
+9.0%
9,9070.0%0.00%0.0%
Q1 2021$413,000
-10.0%
9,907
-7.9%
0.00%
-33.3%
Q4 2020$459,000
+62.2%
10,754
+0.0%
0.00%
+50.0%
Q3 2020$283,000
-1.7%
10,7520.0%0.00%0.0%
Q2 2020$288,00010,7520.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders